Financials
- Market Capitalization 151.55 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.equilliumbio.com
- Headquarter Delaware, United States
- FIGI BBG00LSL8C10
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-35.56
ratio cours/chiffre d'affaires
-3 628.01
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3744 | NRXP NRX Pharmaceuticals, Inc. - Common Stock | 3.55 USD | -1.93% | -0.28% | +12.34% | +99.44% | 153.70 M USD | ||
| 3748 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -1.72% | -8.06% | -21.92% | -40.00% | 151.90 M USD | ||
| 3767 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.27 USD | -4.18% | -6.56% | +0.19% | -19.05% | 146.80 M USD | ||
| 3772 | ADCT ADC Therapeutics SA Common Shares | 1.14 USD | +1.79% | +14.00% | +1.79% | -63.11% | 145.54 M USD |